Finance

Beta
Lists
CGON:NASDAQ
CG Oncology Inc
$53.72
-4.23%
(-2.37) 1D
$53.72
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGON...
Open
$55.85
High
$56.78
Low
$53.52
Mkt. cap
4.74B
Avg. vol.
900.70K
Volume
967.31K
52-wk high
$75.50
52-wk low
$23.65
EPS
-$2.34
Shares outstanding
88.20M
No. of employees
142
Open
$55.85
High
$56.78
Low
$53.52
Mkt. cap
4.74B
Avg. vol.
900.70K
Volume
967.31K
52-wk high
$75.50
52-wk low
$23.65
EPS
-$2.34
Shares outstanding
88.20M
No. of employees
142
Analyst outlook
Analyst Ratings
Based on 14 analysts giving stock ratings to CGON in the past 3 months
Strong Buy
Buy
13
Hold
1
Sell
0
12 month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CGON in the last 3 months.
Highest
Current $53.72
$108.00 (+101.04%)
Average
$92.50 (+72.19%)
Lowest
$80.00 (+48.92%)
News stories
From sources across the web
About CG Oncology Inc
CEO-
Employees142
Founded2010
HeadquartersIrvine, California, United States
SectorBiotechnology
Websitecgoncology.com
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.71 / -$0.54
-31.53%miss
Revenue / Est. (USD)
1.08M / 453.03K
+139.06%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
1.67M
2.32M
1.08M
Cost of goods sold
31.33M
29.46M
33.03M
46.69M
Cost of revenue
31.33M
29.46M
33.03M
46.69M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.41M
23.33M
17.99M
20.78M
Operating expense
17.41M
23.33M
17.99M
20.78M
Total operating expenses
48.74M
52.80M
51.02M
67.47M
Operating income
-48.74M
-51.13M
-48.70M
-66.39M
Other non operating income
-4.00K
-100.00K
-53.00K
-101.00K
EBT including unusual items
-41.43M
-43.81M
-41.31M
-60.20M
EBT excluding unusual items
-41.43M
-43.81M
-41.31M
-60.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-41.43M
-43.81M
-41.31M
-60.20M
Net profit margin
-
-2,629.53%
-1,779.03%
-5,558.82%
Earnings per share
-0.54
-0.57
-0.51
-0.71
Interest and investment income
7.32M
7.42M
7.44M
6.29M
Interest expense
-
-
-
-
Net interest expenses
7.32M
7.42M
7.44M
6.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
-48.58M
-50.71M
-47.85M
-65.55M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer